glp-1 shortage us FDA restricts non-approved compounded weight loss products North Carolina among the states

Sometimes its addressing metabolic factors, hormonal issues, or considering interventions that create lasting change

Many of the companies have started offering GLP-1 medications for weight loss as demand for these drugs has exploded

Muscle loss slows resting metabolism, increases the risk of weight regain after stopping, and in older patients, significantly impacts physical function and fall risk

Microdosing GLP-1 lacks clinical trial evidence and regulatory approval, making its safety profile unknown

Like obstructions of the small intestine, bowel obstructions could lead to tissue death, peritonitis, or sepsis without proper treatment